The influence of leupeptin, molybdate and calcium ions on estrogen receptor stability.
D002118:Calcium / Q000494:pharmacology*; D002413:Cations, Divalent; D003600:Cytosol / Q000378:metabolism; D004355:Drug Stability; D005260:Female; D006801:Humans; D007976:Leupeptins / Q000494:pharmacology*; D008982:Molybdenum / Q000494:pharmacology*; D009215:Myometrium / Q000378:metabolism; D009842:Oligopeptides / Q000494:pharmacology*; D010447:Peptide Hydrolases / Q000378:metabolism; D011480:Protease Inhibitors / Q000494:pharmacology; D011960:Receptors, Estrogen / Q000187:drug effects / Q000378:metabolism*
D002413:Cations, Divalent; D007976:Leupeptins; D009842:Oligopeptides; D011480:Protease Inhibitors; D011960:Receptors, Estrogen; D008982:Molybdenum; C024687:sodium molybdate(VI); D010447:Peptide Hydrolases; D002118:Calcium